Glac Biotech Co, Ltd.
Glac Biotech is a leading and innovative contract manufacturing company of probiotics and postbiotics in Taiwan. We specialize in clinically-tested, patented, and efficacy probiotic and postbiotic ingredients, and customizable nutraceutical products with a focus on food and beverage, dietary supplement, and healthcare markets.
Since established in 2008, Glac has been dedicated to the field of functional probiotics and postbiotics for decades. We have developed over 1,000 probiotic strains, efficacy verification, and have established an independent microbial strain database.
Our functional probiotics cover Gastrointestinal Health, Immunity Support, Urogenital Health, Oral Care, Sleep Aid, Liver & Uric acid Management, Glucose Control, Weight Management, and more with our world-exclusive PRONULIFE.
|Sales markets||Asia; Australia; Central/South America; Eastern Europe; North America; Western Europe|
|Primary business activity||Contract Manufacturer|
|Affiliated categories:||Food Supplements / Nutraceuticals |Postbiotics |Prebiotics More|
Fi Europe28 - 30 Nov 2023 Frankfurt, Germany We were at stand 3.0H65 See our Exhibitor Profile See full Exhibitor List
Vitafoods Asia 202320 - 22 Sept 2023 Bangkok, Thailand We were at stand F01 See our Exhibitor Profile See full Exhibitor List
Our Top products
Lactobacillus rhamnosus MP108
Specification： 300 billion CFU/g
Package：1kg a bag with nitrogen filling and vacuum packing.
Shelf Life：24 months
Strain Origin：Isolated from healthy infants’ intestine with no microbial domestication and mutation process.
Application： √ Intestine Health √ Immune Healt...
Totipro®Postbiotics PE0401 for Digestive Health Application
Totipro® Postbiotics PE0401 is thie lactic acid bacteria fermentate made using probiotics that go through fermentation, heating, and drying processes has been clinically proven to support the immune system and positively modulate the gut microbiome.
In our clinical study, we found that tak...
Specification：100 billion CFU/g
Probiotic blend: Bifidobacterium longum subsp. longum OLP-01, Lactobacillus plantarum PL-02, Lactococcus lactis LY-66
Packing size：1kg a bag with nitrogen filling and vacuum packing.
Shelf Life：24 months
News about Glac Biotech Co, Ltd.
17 Oct 2023
Asia Number One! Glac Totipro®Postbiotics PE0401 Named WINNER at NutraIngredients Asia Awards 2023!
New Proud Achievement in the World of Postbiotics! Totipro®Postbiotics PE0401 has earned recognition as the FIRST in the world to excel in the "Ingredient: Microbiome Modulation" category, specifically for gastrointestinal function enhancement!Read more
26 Apr 2023
Glac Biotech Launches Clinically Tested Postbiotic Ingredients for Oral and Intestinal Health
Postbiotics, which consist of inanimate microorganisms and their metabolites, have become a validated class of ingredients supported by a large amount of science evidence showing similar outcomes to probiotics without the challenges of thermo-limitation. Glac Biotech, a contract manufacturer at the forefront of postbiotics in Taiwan, has been able to launch clinically proven ingredients：Totipro® PE0301(Oral Health) and Totipro® PE0401(Inte...Read more
24 Apr 2023
Glac B. animalis subsp. Lactis CP-9 has been selected as a finalist in the NutraIngredient Awards Europe 2023
Glac are thrilled to announce that our human breast milk-derived probiotic Bifidobacterium animalis subsp. Lactis CP-9 has been selected as a finalist in the NutraIngredient Awards Europe 2023: Weight Management category!Read more